Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice.
about
Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field testHematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice.Therapeutic approaches for lysosomal storage diseasesNeonatal Bone Marrow Transplantation in MPS IIIA Mice.Glycan-based biomarkers for mucopolysaccharidoses.Continual Low-Dose Infusion of Sulfamidase Is Superior to Intermittent High-Dose Delivery in Ameliorating Neuropathology in the MPS IIIA Mouse BrainEmerging therapies for neurodegenerative lysosomal storage disorders - from concept to reality.Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.Gene delivery strategies for the treatment of mucopolysaccharidoses.Abnormal gangliosides are localized in lipid rafts in Sanfilippo (MPS3a) mouse brain.Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA.Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain.Disease stage determines the efficacy of treatment of a paediatric neurodegenerative disease.
P2860
Q27317299-B09E212C-C1F7-49C4-A2FC-31369C3A15BAQ30524212-F2C2442D-4A39-4F17-AC37-55A4DBDF15FDQ34311420-EE6764CA-99BE-4934-B433-0E7027A603D8Q36590943-DC7A39EB-0AA1-4FD8-8D05-DCB12FBD918AQ37161285-DFA842E6-5C95-478B-8951-28C3D6423B4EQ37329316-C5F6EC3D-0316-44C6-817B-8080FEFE5079Q37876354-FE3401D6-AB4C-4492-A2DE-4444DCCA8FC5Q38040710-FEBF22F2-1AFB-438C-A234-79F05A5C1A56Q38180810-4DC422D7-45F5-43FF-BA78-E1D58AC79A7AQ40469071-1338E84F-3994-4C53-AE7B-50781D93D277Q48263257-A949FF21-350B-4FB6-8050-2578A08BDE25Q48448348-A608D401-59CE-4986-8E3A-FA94D49CD935Q48633842-E730CFA0-D46D-4801-BEDC-0740B3423897
P2860
Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Allogeneic stem cell transplan ...... ysaccharidosis type IIIA mice.
@en
Allogeneic stem cell transplan ...... ysaccharidosis type IIIA mice.
@nl
type
label
Allogeneic stem cell transplan ...... ysaccharidosis type IIIA mice.
@en
Allogeneic stem cell transplan ...... ysaccharidosis type IIIA mice.
@nl
prefLabel
Allogeneic stem cell transplan ...... ysaccharidosis type IIIA mice.
@en
Allogeneic stem cell transplan ...... ysaccharidosis type IIIA mice.
@nl
P2093
P1476
Allogeneic stem cell transplan ...... ysaccharidosis type IIIA mice.
@en
P2093
Hanan Hannouche
John J Hopwood
Sofia Hassiotis
Tina Rozaklis
P304
P356
10.1016/J.EXPNEUROL.2010.07.024
P407
P577
2010-07-27T00:00:00Z